CytomX Therapeutics Inc (CTMX)
5.13
+3.50
(+214.72%)
USD |
NASDAQ |
May 01, 16:00
4.50
-0.63
(-12.28%)
Pre-Market: 08:14
CytomX Therapeutics Net Income (Quarterly): 0.837M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.837M |
September 30, 2023 | 2.992M |
June 30, 2023 | -1.087M |
March 31, 2023 | -3.311M |
December 31, 2022 | -8.775M |
September 30, 2022 | -29.06M |
June 30, 2022 | -29.50M |
March 31, 2022 | -31.98M |
December 31, 2021 | -58.49M |
September 30, 2021 | -22.58M |
June 30, 2021 | -19.24M |
March 31, 2021 | -15.55M |
December 31, 2020 | -46.64M |
September 30, 2020 | -14.71M |
June 30, 2020 | -15.68M |
March 31, 2020 | 12.20M |
December 31, 2019 | -66.04M |
September 30, 2019 | -23.70M |
June 30, 2019 | -28.96M |
Date | Value |
---|---|
March 31, 2019 | -14.12M |
December 31, 2018 | -32.23M |
September 30, 2018 | -23.43M |
June 30, 2018 | -13.45M |
March 31, 2018 | -15.49M |
December 31, 2017 | 0.621M |
September 30, 2017 | -10.25M |
June 30, 2017 | -25.22M |
March 31, 2017 | -8.257M |
December 31, 2016 | -14.03M |
September 30, 2016 | -14.66M |
June 30, 2016 | -14.18M |
March 31, 2016 | -16.03M |
December 31, 2015 | -11.49M |
September 30, 2015 | -11.87M |
June 30, 2015 | -5.806M |
March 31, 2015 | -6.211M |
December 31, 2014 | -4.787M |
September 30, 2014 | -3.589M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-66.04M
Minimum
Dec 2019
12.20M
Maximum
Mar 2020
-21.01M
Average
-19.24M
Median
Jun 2021
Net Income (Quarterly) Benchmarks
Ocular Therapeutix Inc | -29.22M |
Bristol-Myers Squibb Co | -11.91B |
ACADIA Pharmaceuticals Inc | 45.80M |
Cytokinetics Inc | -136.90M |
Calidi Biotherapeutics Inc | -8.229M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 26.61M |
Total Expenses (Quarterly) | 27.21M |
EPS Diluted (Quarterly) | 0.01 |
Enterprise Value | 172.90M |
Profit Margin (Quarterly) | 3.15% |
Earnings Yield | -0.39% |
Normalized Earnings Yield | -0.3899 |